Search results for CD80 antibody

CD80 antibody (MEM-233) [APC], Covalab, Ref 00114812

CD80 antibody (MEM-233) [FITC], Covalab, Ref 00114814

CD80 antibody (MEM-233) [PE], Covalab, Ref 00114817

PE Anti-CD80 antibody [16-10A1], Abcam, AB93507

PE Anti-CD80 antibody [MEM-233], Abcam, AB69778

The purified antibody is conjugated with R-Phycoerythrin (PE) under optimum conditions.

PerCP Anti-CD80 antibody [MEM-233], Abcam, AB82410

Anti-CD80 antibody [BLR237K] - BSA free, Abcam, AB314098

REACH authorisation Abcam has not and does not intend to apply for the REACH Authorisation of customers' uses of products that contain European Authorisation list (Annex XIV) substances. It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.

Anti-CD80 antibody [IDEC-114 (Galiximab)], Abcam, AB275981

APC Anti-CD80 antibody [16-10A1], Abcam, AB95549

APC Anti-CD80 antibody [EPR22127-251], Abcam, AB314266

Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .